[wpml_language_selector_widget]

Symptoms and Diagnosis

The International Classification of Sleep Disorders (ICSD) sets forth the diagnostic criteria for IH as follows:1,2

  • Daily periods of irrepressible need to sleep or daytime lapses into sleep occurring for at least 3 months
  • No cataplexy (sudden loss of muscle tone while awake, leading to loss of muscle control)
  • Fewer than 2 sleep-onset rapid eye movement periods (SOREMPs) or no SOREMPs if the REM latency on the preceding nocturnal polysomnography was ≤15 minutes
  • PSG and MSLT findings not consistent with narcolepsy type 1 or 2
  • Presence of at least 1 of the following:
    • MSLT shows a mean sleep latency of ≤8 minutes
    • Total 24-hour sleep time is ≥11 hours
  • Findings are not better explained by another sleep disorder, or use of drugs or medications

A diagnosis of IH will involve a careful examination and clinical history from your doctor. He/she will pay particular attention to the possibility of other disorders with similar symptoms. The doctor will also often conduct certain sleep related tests, including:

  • Actigraphy: uses a wristwatch-like device to monitor your movement during sleep over several days or weeks
  • Polysomnography: also known as a sleep test – records brainwaves, oxygen levels, heart rate, breathing and other items during sleep
  • Multiple sleep latency testing: a test where a person is given 4 to 5 opportunities to sleep every 2 hours during normal waking times. The test measures the degree of daytime sleepiness (how quickly the patient falls asleep in each nap, also called sleep latency), and how quickly rapid eye movement (REM) sleep begins

IH versus Narcolepsy

When comparing IH and narcolepsy type 1 (NT1; Table 1 below), the differences are fairly straightforward with regard to cataplexy, sleep quality and naps. However, the distinction between IH and narcolepsy type 2 (NT2) are more difficult. Cataplexy is absent in both disorders, and other components of the “narcolepsy tetrad”, ie, sleep paralysis and hallucinations, are commonly seen in NT2 and about one quarter of IH patients. Similar to IH, long sleep times may be present in NT2.3 As a result of this symptom overlap, distinguishing between IH and NT2 rests entirely on the presence or absence of <2 sleep-onset REM periods in IH (2 or more in NT2).

Diagnostic Challenges

Patients often describe their sleepiness with terms such as “tired,” “fatigue,” or “lack of energy.”4 It is important to distinguish between sleepiness and fatigue. Fatigue is a physical feeling that may occur in a variety of other disorders, such as depression or Parkinson disease. Unlike sleepiness, patients who are fatigued do not fall asleep when involved in sedentary activities such as watching television or reading. This distinction is important because “sleepiness” indicates the presence of a sleep disorder or a problem with nighttime sleep. Patients may or may not be aware of their sleepiness before falling asleep, but it often significantly affects quality of life.

The Epworth Sleepiness Scale (ESS) can assist with the screening of individuals as the scores significantly distinguished normal subjects from patients in various diagnostic groups, including obstructive sleep apnea syndrome, narcolepsy, and IH.5

As the onset of IH and other sleep disorders such as narcolepsy may be gradual, diagnosis may not occur until a catastrophic event due to sleepiness (eg, a car accident or reduced work productivity) leads to a patient seeking treatment.

References

  1. Dhillon K, Sankari A. Idiopathic Hypersomnia. StatPearls. Last updated July 31, 2023. (https://www.ncbi.nlm.nih.gov/books/NBK585065/)
  2. American Academy of Sleep Medicine (AASM). International Classification of Sleep Disorders. 3rd ed, text revision. 2023.
  3. Vernet C, Arnulf I. Narcolepsy with long sleep time: A specific entity? Sleep. 2009; 32:1229-1235. doi:10.1093/sleep/32.9.1229
  4. Monderer R, Ahmed IM, Thorpy M. Evaluation of the sleepy patient: Differential diagnosis. Sleep Med Clin. 2017;12:301-312. doi:10.1016/j.jsmc.2017.03.006
  5. Johns MW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep. 1991;14:540-545. doi:10.1093/sleep/14.6.540

All URLs accessed July 8, 2024

Pin It on Pinterest

Scroll to Top

You are now leaving the THRIVE site

The THRIVE Neuroscience Community of Care site is funded by an independent medical education grant from Jazz Pharmaceuticals. The following site is not affiliated with the THRIVE educational initiative and MLG is not responsible for its content.

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers